Does Omicron Help Or Hurt Novavax Stock?
- Thursday, December 9, 2021, 7:13
- Market
- Add a comment
The markets have seen considerable volatility over the last week, as the world awaits more data on the apparently more infectious omicron strain of the novel coronavirus that has spread to several countries. Covid-19 vaccine developer Novavax’s stock has seen particularly large swings as investors..
About the Author
admin123 has written 23527 stories on this site.
